MYRIAD GENETICS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | — | $739.6M | $68.5M |
| FY2017 | $99.1M | $768.4M | $102.4M |
| FY2018 | $9.3M | $966.1M | $110.9M |
| FY2019 | $233.5M | $1.09B | $93.2M |
| FY2020 | $224.4M | $918.2M | $163.7M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | — | $739.6M | $68.5M |
| FY2017 | $99.1M | $768.4M | $102.4M |
| FY2018 | $9.3M | $966.1M | $110.9M |
| FY2019 | $233.5M | $1.09B | $93.2M |
| FY2020 | $224.4M | $918.2M | $163.7M |